Free Consultation with Bard Avaulta Mesh Lawyers

Marc J. Bern & Partners and its professional team are investigating potential lawsuits for women who were implanted with a Bard Avaulta mesh to treat pelvic organ prolapse (POP) and suffered severe internal injuries.

Women may be entitled to financial compensation through Bard Avaulta vaginal mesh lawsuit if they have experienced serious complications after surgery, such as pain, infection, erosion of the mesh or other problems. It is not necessary for women to know the type of surgical mesh they received during their transvaginal surgery. Request a free consultation and claim evaluation.


The Bard Avaulta Anterior and Posterior Biosynthetic Support System, also commonly referred to as Bard Avaulta Mesh or Bard Avaulta System, is a vaginal mesh created by C.R. Bard to correct and restore normal vaginal structure after a pelvic organ prolapse (POP).

Bard Avaulta Cases

Bard Avaulta mesh lawsuits are being reviewed for women who have experienced:

  • Infection
  • Erosion of the Mesh
  • Urinary Problems
  • Pelvic Pain
  • Vaginal Pain
  • Hardening of the Mesh
  • Injury to Nearby Organs
  • Difficulty during Sex


Pelvic organ prolapse, which sometimes occurs in women after childbirth or surgery, causes the womb to fall into the vaginal area.  This can also lead to the bladder and bowels slipping out of place and putting pressure on the vagina, which causes pain and discomfort, as well as urinary incontinence in some cases.  However, a growing number of women treated with the Bard Avaulta system have indicated that defects in the design of the vaginal mesh caused them to suffer severe injuries and complications after surgery.

Synthetic mesh systems like the Bard Avaulta have been linked to numerous reports of problems, most frequently involving erosion, extrusion, infection, hardening of the mesh, chronic pain and damage to surrounding organs.  At the 2004 World Health Organization 3rd International Consultation on Incontinence, it was reported that vaginal mesh procedures have an unacceptably high rate of complications.  As a result of the risks, it was recommended that synthetic mesh systems not be used until more approved clinical trials were conducted.

Although the manufacturer, C.R. Bard, knew or should have known about the risk of problems with Bard Avaulta mesh, they continued to market and promote the product as a safe and effective for treatment of pelvic organ prolapse, while minimizing the risks of a Bard Avaulta procedure.

The Bard Avaulta is designed to allow tissue infiltration, which makes it very dangerous and complicated to remove the vaginal mesh.  Complications from Bard Avalta and from mesh removal are life-changing and can be irreversible.  Removal of eroded or infected Bard Avaulta mesh poses a risk of permanent disfigurement, hemorrhage and other potentially life-threatening problems.  Complete Bard Avaulta mesh removal often requires multiple surgery procedures and results in scarring of pelvic tissue and muscles.


At this time, all lawsuits over Bard Avaulta mesh are being reviewed and filed by our lawyers as individual injury claims.  With many cases involving similar allegations being filed on behalf of women throughout the United States, the Bard Avaulta litigation will likely proceed during pretrial proceedings in a very similar fashion to how a class action lawsuit would be managed.  However, each claim will remain an individual Bard Avaulta lawsuit.

Bard Avaulta lawsuits allege that C.R. Bard was negligent in the design and sale of the Avault system.  Since the vaginal mesh was introduced, the manufacturer knew or should have known that the Bard Avaulta mesh was defective and could lead to erosion, hardening and shrinkage of the mesh materials and other complications that may have a devastating impact on women.

Despite the known risks of Bard Avault procedure complications, the manufacturer failed to adequately research the product and establish that it provides both long term and short term efficacy.  In addition, they concealed known risks and failed to warn of the dangers and risks with Bard Avaulta mesh for pelvic organ prolapse.


Marc J. Bern & Partners and its professional team investigate potential claims for women throughout the country who have experienced problems or complications following surgical procedures to treat pelvic organ prolapse.  Even if women are uncertain whether they received the Bard Avaulta system, a free consultation and claim evaluation are available to help determine if financial compensation may be available.